Barr To Pay $142M To Settle Patent Dispute With Organon

Law360, New York (September 8, 2005, 12:00 AM EDT) -- U.S. drug maker Barr Pharmaceuticals will pay Dutch rival Organon International $142 million to settle a patent lawsuit over a generic version of the oral contraceptive Mircette.

Organon, a subsidiary of Dutch industrial conglomerate Akzo Nobel, and Duramed Pharmaceuticals Inc., a subsidiary of Barr Pharmaceuticals, have signed a non-binding letter of intent to settle the pending patent lawsuit concerning a generic version of Mircette, the two companies said in a statement.

Under the terms of the agreement, Barr Pharmaceuticals will acquire all rights relating to Mircette,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.